Cytokines sing the blues: inflammation and the pathogenesis of depression.
Level 5 - mechanism / opinion, no new human data
Narrative review and mechanistic theoretical synthesis without systematic search methodology
PubMed 16316783 · doi:10.1016/j.it.2005.11.006
What was done
This is a narrative review synthesizing literature on the role of inflammatory responses and proinflammatory cytokines in the pathophysiology of depression, evaluating interactions with neurotransmitter metabolism, neuroendocrine function, synaptic plasticity, and autonomic stress pathways.
What was found
The abstract reports that depressed patients have elevated levels of proinflammatory cytokines, acute phase proteins, chemokines, and cellular adhesion molecules. It also notes that therapeutic administration of interferon-alpha leads to depression in up to 50% of patients. No other specific quantitative metrics or sample sizes are reported in the abstract.
Why it matters
The paper outlines the conceptual and biological basis linking immune activation with depressive pathophysiology, suggesting that targeting cytokine signaling pathways could serve as a novel therapeutic strategy.
Limits
As a narrative review, it presents broad thematic summaries without a systematic search protocol, risk-of-bias assessment, or meta-analytic data. The observational associations and mechanistic pathways summarized in the abstract do not establish causality for idiopathic depression.
Cited by
- supports Depression has an inflammatory component in some individuals, as documented in Dr. Charles Raison's 2007 paper 'Cytokines Sing the Blues'.